Treatment Trials for Early Muscle-Invasive Bladder Cancer

The Oncology Brothers, discuss recent clinical trials for early muscle-invasive bladder cancer that have shown promising results with neoadjuvant chemotherapy followed by radical cystectomy as standard of care, immunotherapy trials using checkpoint inhibitors that have demonstrated improved pathological complete response rates, and bladder-sparing approaches combining maximal TURBT with chemoradiation that have shown comparable outcomes to cystectomy in select patients.

EP: 1.Treatment Paradigm for Early Muscle-Invasive Bladder Cancer

Now Viewing

EP: 2.Treatment Trials for Early Muscle-Invasive Bladder Cancer

EP: 3.Utilizing Chemotherapy and Immunotherapy in Bladder Cancer Treatment

EP: 4.Second-Line Treatment and Beyond

EP: 5.Key Adverse Effects With Bladder Cancer Treatment

Recent Videos